🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 483347100
- Market Cap
- Small Cap · $169 Million
- IPO
- 2/28/2019 · $15.00/share
Business: Kaleido Biosciences, Inc. is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health. The Company has built a human-centric proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes.
Company Contact
- CEO
- Alison Lawton
- CFO
- William Duke
- Headquarters
- 65 Hayden Avenue, Lexington, MA 02421
- Phone
- 617-674-9000
- Investor Relations
- Amy Reilly · 617-890-5721 · ir@kaleido.com